Incy Healthcare Profile
Key Indicators
- Authorised Capital ₹ 1.50 Cr
as on 16-07-2024
- Paid Up Capital ₹ 1.34 Cr
as on 16-07-2024
- Company Age 24 Year, 7 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 3.47 Cr
as on 16-07-2024
- Revenue 3.66%
(FY 2023)
- Profit 30.09%
(FY 2023)
- Ebitda -8.08%
(FY 2023)
- Net Worth 7.59%
(FY 2023)
- Total Assets -3.11%
(FY 2023)
About Incy Healthcare
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.50 Cr and a paid-up capital of Rs 1.34 Cr.
The company currently has active open charges totaling ₹3.47 Cr.
Atulbhai Shah and Bina Shah serve as directors at the Company.
- CIN/LLPIN
U24231GJ2000PTC038040
- Company No.
038040
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
19 May 2000
- Date of AGM
29 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Company Details
- Location
Ahmedabad, Gujarat, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Incy Healthcare Private Limited offer?
Incy Healthcare Private Limited offers a wide range of products and services, including Sexual Wellness Products, Fertility Enhancer, Common Disease Medicines, Pharmaceutical Tablets, Brain & Nervous System Drugs, Antidepressant & Anti Anxiety Medicines, Ayurvedic,Herbal Products & Medicine, Herbal Capsules, Nutraceuticals & Dietary Supplements, Fitness Supplements.
Who are the key members and board of directors at Incy Healthcare?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Atulbhai Shah  | Director | 19-May-2000 | Current |
| Bina Shah | Director | 19-May-2000 | Current |
Financial Performance of Incy Healthcare.
Incy Healthcare Private Limited, for the financial year ended 2023, experienced modest growth in revenue, with a 3.66% increase. The company also saw a substantial improvement in profitability, with a 30.09% increase in profit. The company's net worth moved up by a moderate rise of 7.59%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Incy Healthcare?
In 2023, Incy Healthcare had a promoter holding of 50.87% and a public holding of 49.13%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 27 Mar 2017 | ₹3.47 Cr | Open |
How Many Employees Work at Incy Healthcare?
Unlock and access historical data on people associated with Incy Healthcare, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Incy Healthcare, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Incy Healthcare's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
